Literature DB >> 21403672

Neurodegenerative disease: Tracking disease progress in Huntington disease.

Roger A Barker, Sarah L Mason.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21403672     DOI： 10.1038/nrneurol.2011.37

Source DB:  PubMed          Journal:  Nat Rev Neurol        ISSN： 1759-4758            Impact factor:   42.937


× No keyword cloud information.
  9 in total

1.  A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's Disease Collaborative Research Group.

Authors: 
Journal:  Cell       Date:  1993-03-26       Impact factor: 41.582

2.  Biological and clinical changes in premanifest and early stage Huntington's disease in the TRACK-HD study: the 12-month longitudinal analysis.

Authors:  Sarah J Tabrizi; Rachael I Scahill; Alexandra Durr; Raymund Ac Roos; Blair R Leavitt; Rebecca Jones; G Bernhard Landwehrmeyer; Nick C Fox; Hans Johnson; Stephen L Hicks; Christopher Kennard; David Craufurd; Chris Frost; Douglas R Langbehn; Ralf Reilmann; Julie C Stout
Journal:  Lancet Neurol       Date:  2010-12-02       Impact factor: 44.182

3.  Confirmation of subtle motor changes among presymptomatic carriers of the Huntington disease gene.

Authors:  S C Kirkwood; E Siemers; C Bond; P M Conneally; J C Christian; T Foroud
Journal:  Arch Neurol       Date:  2000-07

4.  Disintegration of the sleep-wake cycle and circadian timing in Huntington's disease.

Authors:  A Jennifer Morton; Nigel I Wood; Michael H Hastings; Carrie Hurelbrink; Roger A Barker; Elizabeth S Maywood
Journal:  J Neurosci       Date:  2005-01-05       Impact factor: 6.167

5.  Tapping linked to function and structure in premanifest and symptomatic Huntington disease.

Authors:  N Bechtel; R I Scahill; H D Rosas; T Acharya; S J A van den Bogaard; C Jauffret; M J Say; A Sturrock; H Johnson; C E Onorato; D H Salat; A Durr; B R Leavitt; R A C Roos; G B Landwehrmeyer; D R Langbehn; J C Stout; S J Tabrizi; R Reilmann
Journal:  Neurology       Date:  2010-11-10       Impact factor: 9.910

6.  Homozygosity for CAG mutation in Huntington disease is associated with a more severe clinical course.

Authors:  Ferdinando Squitieri; Cinzia Gellera; Milena Cannella; Caterina Mariotti; Giuliana Cislaghi; David C Rubinsztein; Elisabeth W Almqvist; David Turner; Anne-Catherine Bachoud-Lévi; Sheila A Simpson; Martin Delatycki; Vittorio Maglione; Michael R Hayden; Stefano Di Donato
Journal:  Brain       Date:  2003-04       Impact factor: 13.501

7.  Huntington disease: pathogenesis, biomarkers, and approaches to experimental therapeutics.

Authors:  Christopher A Ross; Ira Shoulson
Journal:  Parkinsonism Relat Disord       Date:  2009-12       Impact factor: 4.891

8.  The metabolic profile of early Huntington's disease--a combined human and transgenic mouse study.

Authors:  Anna O G Goodman; Peter R Murgatroyd; Gema Medina-Gomez; Nigel I Wood; Nicholas Finer; Antonio J Vidal-Puig; A Jennifer Morton; Roger A Barker
Journal:  Exp Neurol       Date:  2008-01-19       Impact factor: 5.330

9.  Detection of Huntington's disease decades before diagnosis: the Predict-HD study.

Authors:  J S Paulsen; D R Langbehn; J C Stout; E Aylward; C A Ross; M Nance; M Guttman; S Johnson; M MacDonald; L J Beglinger; K Duff; E Kayson; K Biglan; I Shoulson; D Oakes; M Hayden
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-12-20       Impact factor: 10.154
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.